These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16371154)

  • 21. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.
    Black GF; Weir RE; Floyd S; Bliss L; Warndorff DK; Crampin AC; Ngwira B; Sichali L; Nazareth B; Blackwell JM; Branson K; Chaguluka SD; Donovan L; Jarman E; King E; Fine PE; Dockrell HM
    Lancet; 2002 Apr; 359(9315):1393-401. PubMed ID: 11978337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma production by mononuclear cells in Bacille Calmette-Guérin-revaccinated healthy volunteers predicted long-term antimycobacterial responses in a randomized controlled trial.
    Oliveira ES; Marinho JM; Barbosa T;
    Vaccine; 2013 Aug; 31(37):3778-82. PubMed ID: 23684832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins.
    Wedlock DN; Keen DL; McCarthy AR; Andersen P; Buddle BM
    Vet Immunol Immunopathol; 2002 May; 86(1-2):79-88. PubMed ID: 11943331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination.
    Hoft DF; Kemp EB; Marinaro M; Cruz O; Kiyono H; McGhee JR; Belisle JT; Milligan TW; Miller JP; Belshe RB
    J Lab Clin Med; 1999 Sep; 134(3):244-52. PubMed ID: 10482309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers.
    Hoft DF; Blazevic A; Abate G; Hanekom WA; Kaplan G; Soler JH; Weichold F; Geiter L; Sadoff JC; Horwitz MA
    J Infect Dis; 2008 Nov; 198(10):1491-501. PubMed ID: 18808333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses.
    Hoft DF; Brown RM; Belshe RB
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S217-22. PubMed ID: 10875787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.
    Dai FY; Wang JF; Gong XL; Bao L
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens.
    Mori T; Sakatani M; Yamagishi F; Takashima T; Kawabe Y; Nagao K; Shigeto E; Harada N; Mitarai S; Okada M; Suzuki K; Inoue Y; Tsuyuguchi K; Sasaki Y; Mazurek GH; Tsuyuguchi I
    Am J Respir Crit Care Med; 2004 Jul; 170(1):59-64. PubMed ID: 15059788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy.
    Lalor MK; Ben-Smith A; Gorak-Stolinska P; Weir RE; Floyd S; Blitz R; Mvula H; Newport MJ; Branson K; McGrath N; Crampin AC; Fine PE; Dockrell HM
    J Infect Dis; 2009 Mar; 199(6):795-800. PubMed ID: 19434928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.
    Weir RE; Black GF; Nazareth B; Floyd S; Stenson S; Stanley C; Branson K; Sichali L; Chaguluka SD; Donovan L; Crampin AC; Fine PE; Dockrell HM
    Clin Exp Immunol; 2006 Dec; 146(3):390-9. PubMed ID: 17100757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle.
    Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ
    Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal BCG Vaccination Reduces Interferon-γ Responsiveness to Heterologous Pathogens in Infants From a Randomized Controlled Trial.
    Freyne B; Messina NL; Donath S; Germano S; Bonnici R; Gardiner K; Casalaz D; Robins-Browne RM; Netea MG; Flanagan KL; Kollmann T; Curtis N;
    J Infect Dis; 2020 Jun; 221(12):1999-2009. PubMed ID: 31990350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin.
    Wu B; Huang C; Garcia L; Ponce de Leon A; Osornio JS; Bobadilla-del-Valle M; Ferreira L; Canizales S; Small P; Kato-Maeda M; Krensky AM; Clayberger C
    Infect Immun; 2007 Jul; 75(7):3658-64. PubMed ID: 17502394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.